Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M953Revenue $M14.2Net Margin (%)-787.6Z-Score7.7
Enterprise Value $M729EPS $-3.3Operating Margin %-635.0F-Score4
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-787.6Higher ROA y-yY
Price/Book3.910-y EBITDA Growth Rate %-9.1Quick Ratio6.6Cash flow > EarningsY
Price/Sales52.45-y EBITDA Growth Rate %25.2Current Ratio6.6Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-38.4Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-45.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M40.7ROI % (ttm)-300.9Gross Margin Increase y-yN

Gurus Latest Trades with SRPT

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SRPTGeorge Soros 2014-03-31 Reduce-0.04%$17.91 - $30.29
($25.36)
$ 20.33-20%Reduce -89.27%25,000
SRPTGeorge Soros 2013-12-31 Reduce-0.22%$12.89 - $53.81
($29.58)
$ 20.33-31%Reduce -64.98%233,000
SRPTGeorge Soros 2013-09-30 Add0.12%$30.906 - $47.97
($38.37)
$ 20.33-47%Add 56.28%665,274
SRPTGeorge Soros 2013-03-31 Add0.08%$23.97 - $36.95
($28.83)
$ 20.33-30%Add 82.54%413,329
SRPTGeorge Soros 2012-12-31 Add0.05%$14.99 - $44.93
($26.74)
$ 20.33-24%Add 184.13%226,429
SRPTJean-Marie Eveillard 2012-03-31 Sold Out $4.5 - $9.6
($6.06)
$ 20.33236%Sold Out0
SRPTJean-Marie Eveillard 2011-12-31 Reduce$3.24 - $6.54
($5.04)
$ 20.33303%Reduce -83.33%50,000
SRPTJean-Marie Eveillard 2011-09-30 Add$6.3 - $9.9
($7.92)
$ 20.33157%Add 50%300,000
SRPTJean-Marie Eveillard 2011-06-30 Buy $8.1 - $11.22
($9.66)
$ 20.33110%New holding, 200000 sh.200,000
SRPTGeorge Soros 2006-03-31 Buy 0.08%$24.54 - $50.45
($41.39)
$ 20.33-51%New holding, 308100 sh.308,100
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SRPT is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SRPT George Soros 2014-03-3125,0000.060.01-89.27%
Premium Most recent portfolio changes are included for Premium Members only!


SRPT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CHASE ANTHONY RDirector 2013-11-14Buy10,000$13.9567.96view
Aphale JayantSVP Technical Operations 2013-11-12Sell15,933$12.5686.54view
BEHRENS M KATHLEENDirector 2013-09-16Buy6,500$37.04-36.74view
HODGMAN JOHNDirector 2013-09-03Sell5,556$34.97-33view
CHASE ANTHONY RDirector 2013-08-22Buy3,500$32.68-28.3view
Mahatme SandeshSenior Vice President, CFO 2013-08-20Buy5,000$31.1-24.66view
Price Ben GilDirector 2013-08-19Buy500$31.18-24.86view
CHASE ANTHONY RDirector 2013-06-14Buy10,000$38.5-39.14view
CHASE ANTHONY RDirector 2012-11-28Sell10,000$29.46-20.47view
CHASE ANTHONY RDirector 2012-11-14Sell10,000$25.7-8.83view

Press Releases about SRPT :

    Quarterly/Annual Reports about SRPT:

    News about SRPT:

    Articles On GuruFocus.com
    Insiders Are Buying Fate Therapeutics Oct 09 2013 
    comment on SRPT Mar 16 2013 
    comment on SRPT Mar 16 2013 
    comment on SRPT Feb 16 2013 

    More From Our Partners
    Morning Market Losers Jul 24 2014 - BENZINGA

    More From Other Websites
    Here's Why Aegerion and Sarepta Trade Higher Wednesday Jul 30 2014
    Nasdaq stocks posting largest percentage decreases Jul 29 2014
    [$$] Sarepta CEO Sheds Some Sway Over Management Jul 29 2014
    Sarepta Therapeutics upgraded by WBB Securities Jul 29 2014
    Stop Squabbling, Mom Tells Troubled Biotech: 'Just Get My Kid the Drug' Jul 28 2014
    [$$] Chief Scientist Out at Sarepta Therapeutics Jul 25 2014
    Sarepta fired CSO not involved in eteplirsen, The Street reports Jul 24 2014
    The Story Behind Sarepta's Firing of its Top Scientist Jul 24 2014
    Sarepta terminates Chief Scientific Officer Arthur Krieg Jul 24 2014
    SAREPTA THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Jul 24 2014
    [video] PTC Therapeutics CFO: Positive News on Translarna Just the Start Jul 23 2014
    Edelman's Perceptive Advisors Buying Amicus Therapeutics Ahead Of Phase III Data Release Jul 23 2014
    Your first trade for Friday Jul 17 2014
    [video] Fast Money Final Trade: GOOGL, MSFT & more Jul 17 2014
    The Zacks Analyst Blog Highlights: AbbVie, Shire, Gilead Sciences, Sarepta Therapeutics and Celgene Jul 17 2014
    Sarepta Plunges on Eteplirsen Study Results Jul 11 2014
    Today's Dead Cat Bounce Stock Is Sarepta Therapeutics (SRPT) Jul 11 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide